The Treatment of Epilepsy 2009
DOI: 10.1002/9781444316667.ch22
|View full text |Cite
|
Sign up to set email alerts
|

Management of Side‐Effects of Antiepileptic Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
2
2
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…The clearance of perampanel has also been reported to be increased threefold and twofold by carbamazepine and phenytoin, respectively (Fycompa, 2013), suggesting that its dose requirements may also be impacted by type of co-medication. For some AEDs such as carbamazepine and tiagabine, which exhibit considerably shorter half-lives in the presence of enzyme inducers, enzyme induction also increases fluctuations in serum drug concentrations during a dosing interval, potentially leading to intermittent adverse effects at the time of peak concentration and breakthrough seizures at the time of trough (Riva et al, 1985;Zaccara et al, 2004;Tothfalusi et al, 2008). In these cases, more frequent daily dosing, or the use of extended release formulations, can improve clinical response (Canger et al, 1990).…”
Section: Interactions Resulting In Decreased Serum Concentration Of T...mentioning
confidence: 99%
“…The clearance of perampanel has also been reported to be increased threefold and twofold by carbamazepine and phenytoin, respectively (Fycompa, 2013), suggesting that its dose requirements may also be impacted by type of co-medication. For some AEDs such as carbamazepine and tiagabine, which exhibit considerably shorter half-lives in the presence of enzyme inducers, enzyme induction also increases fluctuations in serum drug concentrations during a dosing interval, potentially leading to intermittent adverse effects at the time of peak concentration and breakthrough seizures at the time of trough (Riva et al, 1985;Zaccara et al, 2004;Tothfalusi et al, 2008). In these cases, more frequent daily dosing, or the use of extended release formulations, can improve clinical response (Canger et al, 1990).…”
Section: Interactions Resulting In Decreased Serum Concentration Of T...mentioning
confidence: 99%
“…Habituation to central nervous system (CNS) side effects is common for CNS-active drugs, but the time course is not well understood. Many adverse CNS effects can be minimized by gradual titration, owing to occurrence of pharmacodynamic tolerance [6]. Even some idiosyncratic reactions can also be diminished by use of low starting doses and gradual titration [7].…”
Section: Introductionmentioning
confidence: 99%